Meiji Seika Pharma Co., Ltd.
Quick facts
Marketed products
- Daunorubicin Hydrochloride · Oncology
Phase 3 pipeline
- Matching Vehicle Solution
Matching Vehicle Solution is a pharmaceutical vehicle or excipient formulation designed to match the properties of an active pharmaceutical ingredient for comparative or control purposes in clinical trials.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Meiji Seika Pharma Co., Ltd.
What are Meiji Seika Pharma Co., Ltd.'s marketed drugs?
Top marketed products include Daunorubicin Hydrochloride.
What is Meiji Seika Pharma Co., Ltd.'s pipeline?
Meiji Seika Pharma Co., Ltd. has 1 drugs in Phase 3, 2 in Phase 2, 5 in Phase 1. Late-stage candidates include Matching Vehicle Solution.
Related
- Daunorubicin Hydrochloride · Oncology
- Sector hub: All tracked pharma companies